ArticleBMC cancer2022

Neutrophil-to-lymphocyte ratio as a prognostic factor for patients with metastatic or recurrent breast cancer treated using capecitabine: a retrospective study.

Shigemasa Takamizawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.